Saakshi Medtech Peer Comparison

NSE: SAAKSHI

₹372.00

₹-0.75 (-0.20%)

As on 06-Nov-2026IST

Market cap

₹732 Cr

Revenue (TTM)

₹116 Cr

P/E Ratio

59.5

P/B Ratio

5.2

Div. Yield

0 %

Edit

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Market cap (₹ Cr)	732	16,293	1,194	326	290
Revenue (₹ Cr)	116	2,134	342	183	174
Net Profit (₹ Cr)	12.29	309.79	55.72	12.72	4.76
Net Margin (%)	10.59	13.89	16.04	6.90	2.64
RoE (%)	11.80	9.92	25.55	10.39	2.58
Price to Earnings	59.53	51.18	21.42	29.96	60.94
Price-To-Book	5.24	4.99	2.45	--	1.54

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Operating Revenue	115.51	1,875.26	341.74	152.30	146.96
Total Income	116.04	2,002.19	347.44	152.65	155.06
Total Expenditure	93.29	1,436.66	243.64	131.80	146.78
EBITDA	22.22	438.59	98.10	20.50	0.18
Depreciation	4.74	115.52	10.79	3.51	2.02
EBIT	17.48	323.08	87.31	16.99	-1.84
Interest	1.35	21.42	19.47	7.89	1.28
Other Income	0.54	126.93	5.70	0.35	8.10
Exceptional Items	--	-6.80	-0.99	--	--
Profit before Tax	16.67	427.47	72.55	9.45	4.98
Provision for Tax	4.38	106.74	16.83	2.76	2.90
Profit after Tax	12.29	320.73	55.72	6.69	2.08

Liabilities (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Shareholder's Funds	110.33	3,106.17	246.19	104.22	180.76
Minority Interest	--	43.07	--	--	--
Non-Current Liabilities	16.71	120.16	101.51	24.01	-0.92
Current Liabilities	29.82	666.53	209.92	91.76	13.78
Total Liabilities	156.99	3,951.60	558.69	220.04	196.16

Assets (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Non-Current Assets	95.54	1,903.19	213.57	89.33	78.94
Current Assets	61.32	2,032.74	344.06	130.66	114.68
Total Assets	156.99	3,951.60	558.69	220.04	196.16
Total Debt*	25.45	341.62	225.48	90.92	0.72
Net Current Assets	31.50	1,366.21	134.14	38.91	100.90
Contingent Liabilities	5.27	50.21	52.55	1.05	4.73

Cashflow (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Cash From Operating Activities	--	246.37	16.38	18.77	3.30
Cash Flow from Investing Activities	--	-225.38	-29.42	-18.27	14.49
Cash from Financing Activities	--	20.15	41.64	-0.78	-19.56
Net Cash Inflow / Outflow	0.00	41.14	28.60	-0.28	-1.77

Ratios

Profitability Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
ROCE (%)	14.32	14.05	22.23	9.62	3.31
ROE (%)	11.80	10.94	25.55	6.96	1.11
ROA (%)	8.54	8.89	11.01	3.27	1.04
EBIT Margin (%)	19.70	30.16	30.37	13.69	5.63
Net Margin (%)	10.59	16.02	16.04	4.38	1.34
Cash Profit Margin (%)	12.56	23.12	18.40	6.70	2.57

Growth Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Revenue Growth (%)	24.96	12.30	9.13	5.13	34.02
EBIT Growth (%)	109.09	3.80	40.81	-12.29	69.11
Net Profit Growth (%)	160.94	-5.27	255.32	-35.79	145.86
EPS Growth (%)	160.94	-4.88	180.69	-40.73	157.91
Book Value Growth (%)	12.53	12.14	29.61	18.37	-6.96

Valuation Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Price / Earnings	25.29	37.47	0.00	20.81	94.46
Price / Book Value	2.82	3.90	0.00	1.34	1.09
Dividend Yield (%)	0.00	0.29	--	0.69	0.00
EV/EBITDA	14.69	21.79	1.59	11.03	18.84
Market Cap (₹ Cr)	310.75	12,069.92	0.00	139.23	196.67

Solvency Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Debt to Equity	0.23	0.11	0.92	0.87	0.00
Short term debt to equity ratio	0.03	0.08	0.36	0.60	0.00
Current Ratio	2.06	3.05	1.64	1.42	8.32
Quick Ratio	1.34	2.40	1.19	0.92	4.88
Interest Coverage	13.37	20.96	4.73	2.20	4.88

Operating Efficiency Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Debtors to sales (%)	22.72	28.33	36.82	38.85	5.27
Asset Turnover	0.94	0.52	0.71	0.74	0.80
Receivable days	64.80	85.20	105.22	135.40	12.70
Inventory Days	56.27	69.58	93.48	102.09	100.27
Payable days	52.79	77.97	146.52	71.73	22.92
Cash Conversion Cycle	68.27	76.82	52.17	165.75	90.04

Annual
Quarterly